Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Koh

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
ACS Applied Materials & Interfaces|August 21, 2020
High-<i>k</i>, Ultrastretchable Self-Enclosed Ionic Liquid-Elastomer Composites for Soft Robotics and Flexible ElectronicsAnkit, Naveen Tiwari, Fanny Ho, et al.
American Journal of Ophthalmology|July 6, 2004
Optic disk and retinal characteristics in myopic childrenLouis Tong, Seang-Mei Saw, Wei-Han Chua, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|April 6, 2017
Recommended Guidelines for Use of Intravitreal Aflibercept With a Treat-and-Extend Regimen for the Management of Neovascular Age-Related Macular Degeneration in the Asia-Pacific Region: Report From a Consensus PanelAdrian Koh, Paolo Lanzetta, Won Ki Lee, et al.
The Journal of Biological Chemistry|June 11, 2025
Bacterial genome encoded ParMsSamson Ali, Adrian Koh, David Popp, et al.
Retina (Philadelphia, Pa.)|December 21, 2020
MANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPYPaul Mitchell, Francisco J Rodríguez, Antonia M Joussen, et al.
Journal of Visualized Experiments : Jove|April 4, 2022
Routine Collection of High-Resolution cryo-EM Datasets Using 200 KV Transmission Electron MicroscopeAdrian Koh, Sagar Khavnekar, Wen Yang, et al.
Ophthalmology. Retina|December 30, 2021
Efficacy Outcomes of Brolucizumab Versus Aflibercept in Neovascular Age-Related Macular Degeneration Patients with Early Residual FluidRishi P Singh, Chirag Jhaveri, Charles C Wykoff, et al.
Eye (London, England)|September 14, 2022
Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomesThibaud Mathis, Frank G Holz, Sobha Sivaprasad, et al.
Retina (Philadelphia, Pa.)|August 7, 2019
REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY: Twelve-Month Results From the LUMINOUS StudyAdrian Koh, Timothy Y Y Lai, Wen Bin Wei, et al.
Ophthalmology|June 24, 2020
HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular DegenerationPravin U Dugel, Rishi P Singh, Adrian Koh, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
ACS Applied Materials & Interfaces|August 21, 2020
High-<i>k</i>, Ultrastretchable Self-Enclosed Ionic Liquid-Elastomer Composites for Soft Robotics and Flexible ElectronicsAnkit, Naveen Tiwari, Fanny Ho, et al.
American Journal of Ophthalmology|July 6, 2004
Optic disk and retinal characteristics in myopic childrenLouis Tong, Seang-Mei Saw, Wei-Han Chua, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|April 6, 2017
Recommended Guidelines for Use of Intravitreal Aflibercept With a Treat-and-Extend Regimen for the Management of Neovascular Age-Related Macular Degeneration in the Asia-Pacific Region: Report From a Consensus PanelAdrian Koh, Paolo Lanzetta, Won Ki Lee, et al.
The Journal of Biological Chemistry|June 11, 2025
Bacterial genome encoded ParMsSamson Ali, Adrian Koh, David Popp, et al.
Retina (Philadelphia, Pa.)|December 21, 2020
MANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPYPaul Mitchell, Francisco J Rodríguez, Antonia M Joussen, et al.
Journal of Visualized Experiments : Jove|April 4, 2022
Routine Collection of High-Resolution cryo-EM Datasets Using 200 KV Transmission Electron MicroscopeAdrian Koh, Sagar Khavnekar, Wen Yang, et al.
Ophthalmology. Retina|December 30, 2021
Efficacy Outcomes of Brolucizumab Versus Aflibercept in Neovascular Age-Related Macular Degeneration Patients with Early Residual FluidRishi P Singh, Chirag Jhaveri, Charles C Wykoff, et al.
Eye (London, England)|September 14, 2022
Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomesThibaud Mathis, Frank G Holz, Sobha Sivaprasad, et al.
Retina (Philadelphia, Pa.)|August 7, 2019
REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY: Twelve-Month Results From the LUMINOUS StudyAdrian Koh, Timothy Y Y Lai, Wen Bin Wei, et al.
Ophthalmology|June 24, 2020
HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular DegenerationPravin U Dugel, Rishi P Singh, Adrian Koh, et al.
Pageof 6